Subscribe to our newsletter and benefit from the latest news on cold chain logisticsRegister
Download the Product CatalogueDownload
inertia of a heat-sensitive healthcare product is 4 times lower than the
thermal inertia of a food product. It cannot withstand transhipment and, if it
is handled in this way, any exposure to temperature fluctuations beyond +2 °C or
+8 °C must be as brief as possible!
Any temperature fluctuation is harmful to the product and results in varying degrees of deterioration. The deterioration of a healthcare product is all the more dangerous because it is invisible.
The medicine may be subject to deterioration by heat, as the result of repeated temperature fluctuations, or deterioration by cold. In the latter case, just one period of exposure is sufficient to cause deterioration of the product. With insulin and vaccines, the active ingredients are rendered inert. With other products their pharmaceutical form is altered (separation of the ingredients, precipitates, burst ampoules, etc.), until the products become toxic due to chemical modifications or microbial contamination. It is therefore essential to maintain the product at a precise temperature between +2 °C and +8 °C.
pharmaceutical products (vaccines, biotechnological products, reagents,
biological specimens, etc.) must be transported under temperature-controlled
conditions. For example:
In the healthcare sector, where the stakes are high, it is necessary to have access to a suitable insulated or cooling packaging solution. Guaranteeing transportation at the correct temperature also guarantees the complete therapeutic efficacy of the treatment.